| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.12 | 9e-05 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.1 | 0.0007 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.098 | 0.002 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.14 | 0.004 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.006 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.007 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.08 | 0.008 |